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Containing High Molecular Weight, Less Soluble Gases 
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Objecfives. The central hypothesis of this study was that 
microbubble survival, and subsequent left ventricular and myo- 
cardial ultrasound contrast, could be improved by altering micro- 
bubble gas to consist of a higher molecular weight (less diffusible) 
and less soluble gas. 
Background. Microbubble survival after intravenous injection 
is shortened because of rapid diffusion of blood-soluble room air 
gases (nitrogen and oxygen) across the permeable bubble mem- 
brane into blood. 
Metho& Thirteen open chest dogs received intravenous injec- 
tions of a constant dose of sonicated dextrose albumin that was 
incubated with either room air or 100% nitrogen, 100% helium or 
100% sulfur bexafluoride. Nitrogen (100%) is less blood soluble 
than room air, whereas helium and sulfur hexatluoride are the 
least soluble. Sulfur hexafluoride has the slowest ditlitsion rate. To 
further decrease the diffusion rate, each sample was administered 
Sonicated albuntin lnd sonicated dextrose. albumin produce 
variable degrees of left ventricular chamber ultrasound con- 
trast after intravenous injection (l-5). Because these micro- 
bubbles are small (4 to 6 pm), they are capable of swift 
transpuhnonary passage. However, this small microbubble size 
is associated with high surface tension (6), which is associated 
with high internal pressure within the microbubble and. thus, 
with large internal concentrations of room air gases (nitrogen 
and oxygen). Therefore. these gases rapidly diffuse out of the 
microbubble down the concentration gradient after intrave- 
nous injection, causing shrinkage of the microbubble and loss 
of ultrasound reflective properties (6). Because these micro- 
bubbles appear to allow diffusion of gases across the microbubble 
membrane, we hypothesized that decreasing the microbubble gas 
solubihty and gas phase dithrsivity would both increase blood gas 
concentration and preserve microbubble size in blood. These 
effects would enhance left ventricular cavity contrast and could 
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during inhalation of room air and again during brief inhalation of 
the same gas with which it had been incubated. 
Results. The highest peak videointensity in the left ventricular 
cavity was produced by the sonicated dextrose albumin incubated 
with sulfur bexatluoride, the gas having lowest blood solubility and 
ditfusion rate, while sulfur bexafluoride was briefly inhaled during 
the period of intravenous injection (peak videointensity 139 2 10 vs. 
54 * 11 for room *air-exposed sonicated dextrose albumin, p < 
0.001). Myocardial contrast was visually evident in >8& of the 
intravenous injections of sulfur hexafluoride-exposed sonicated dtx- 
trose albumin when the agent was given as an g-fold concentrated 
sample during brief inbalation of sulfur hexafluoride. 
Cc~lu.&us. Visual myocardial echoearrliographic contrast is pos- 
sible after intravenous injection of sonicated dextrose albumin if the 
microhubbles contain a gas with low blood soluhility and ditfusivity. 
(J Am CoU Gzrdiol 1995;2.5:509-15) 
produce myocardial ultrasound opacification after intravenous 
microbubble injection. 
Methods 
Canine preparation. The study involved 13 mongrel dogs. 
Each dog underwent open thoracotomy after intrsVenous 
sedation with sodium pentobarbital and subsequent cndotra- 
cheal intubation and ventilation initially with room air. A 
3.5-M& epicardial imaging transducer was placed in a warm 
water bath over the anterior portion of the heart and adjusted 
to produce a short-axis view of the left ventricle at the 
miJpapillary muscle level. 
Intravenous and intraarterial 7F sheaths were placed in the 
right and the left femoral artery and vein. In one venous 
sheath, a 7F pulmonary artery catheter was placed and ad- 
vanced into the pulmonary artery under fluoroscopic or pres- 
sure waveform guidance. This catheter was used to monitor 
pulmonary artery pressures during intravenous injections of 
contrast medium. A 7F pigtail catheter was advanced into the 
left ventricular cavity for monitoring of left ventricular systolic 
and end-diastolic pressures during contrast injections. The 
entire study was approved by the Institutional Animal Care 
and Use Committee and was in compliance with the Position 
of the American Heart Association on Research Animal Use. 
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Table i. Diffusioil Coefficients and Blood Solubilities of the inert 
Gases Used With Sonicated Dextrose Albumin in the Study 
____-. ___ 
Diffusion coe2icients (cm%) 
Blood soluhiiity 
Nitrogen 
0250* 
(I.0 I? 
Hslium Su!fur Hcxa!hrid~ 
0.73 0.101 
II.007 0.006 
*On the basis of Graham’s law (8). 
Preparation of ultrasound contrast agents. The two Joni- 
cated solutions used for this study were 3- to 4-fold dilutions of 
albumin with either 5% or 50% dextrose. The mean size of 
these microbubbles during room air sonication is 5 to 6 pm (7). 
The following stepwise process was performed in formulating 
the different gas-exposed sonicated dextrose albumin micro- 
bubbles. 
Sq 1. Shcation of dextrose albumin. Five percent human 
albumin, 5n% dextrose and 5% dextrose were oitained from 
the hospital pharmacy. Selected aliquots of albumin and 5% or 
50% dextrose were measured into 35-m] syringes. A commer- 
cially available sonicator (Heat Systems Ultrasonics Corp., 
model XL2020) was utilized to create microbubbles. With the 
sonicating horn initially placed just below the surface of the 
aibumin-dextrose mixture, continuous sonication proceeded at 
20,000 Hz with power set to 30% maximal output for 80 2 5 s. 
All samples were prepared in a sterile laminar flow room. 
Step 2. Exposure of gas to sonicated dextrose albumin. 
Eight-milliliter samples of sonicated dextrose albumin were 
then left in room air or exposed to physiologically inert gases 
of varying blood solubility and gas phase diffusivity for 60 min 
(Table 1). These gases (100% nitrogen, 100% helium and 
100% sulfur hexafluoride) were obtained from a commercially 
available distributor (Air Products). As can be seen in Table 1, 
helium is less soluble in blood than is nitrogen (8); helium and 
sulfur hexafluoride have similar solubility (9). but sulfur 
hexafiuoride has a lower gas phase dlffusivity (10). Separate 
8-ml samples of sonicated dextrose albumin were mixed with 
10 ml of each gas in a 35-ml syringe for -60 min before 
intravenous injection. Contincous mixing of the gas with 
microbubbles was achieved by placing the syringe on a hema- 
roiog rrc!:.:r (Barnstead/Thcrmolyne Corp.). 
Step 3. Decanbq gaas from sonicate& dextrose albumin. The 
gas was decanted from the sonicated dextrose albumin after 
60 min of exposure to the gas and immediately before intra- 
venous injection. The syringe containing the gas and micro- 
bubbles was turned upside down, and the gas at the top of the 
syringe was ejected. The 8-A sample of the remaining micro- 
bubbles was then injected intravenously immediately after this 
profess. 
Preparation of concentrated boluses of microbubble solu- 
tions. In four dogs, 16- and 32-ml samples of sonicated 
dextrose albumin were placed in an upright position for -2 h, 
resulting in the formation of an upper white layer (-4 ml) and 
a lower clear layer. Thig clear layer was then decanted and the 
remaining 4-m) sample (thus a 4- and an g-fold concentrated 
sample) was cxpu& to the gas with the highest molecular 
weight and slowest gas phase diffusivity (sulfur hexafluoride) 
for 60 min (the same exposure period as that of the previous 
snmr,ies) before intravenous injection. 
Microbubble analysis. The microbubble *‘oncentration of 
sonicated 5% dextrose albumin and the sonicated dextrose 
albumin samples exposed to 100% nitrogen, helium and sulfur 
hexafluoride were analyzed by using a model ZBI Coulter 
Electronics cuunter. The aperture diameter was 100 pm and 
the sample volume was 500 ~1. Each sonicated dex:rose 
albumin sample was analyzed three times with the use of three 
samples of each contrast agent. The mean microbubble con- 
centration and standard deviation were then calculated for 
each dilution. 
Microbubble size of a sample of sonicated dextrose albumin 
alone and of sonicated dextrose albumin exposed to the 
different gases was determined bv using a hemocytometer 
slfje. A drop of the samp!e WIS $a;& on the slide al’ier 
decanting the gas from the syringe and immediately analyzed 
by light microscopy. 
Study protocol. The dogs underwent intravenous injections 
of sonrcated dextrose albumin solutions that had been exposed 
to the different external gas concentrations for 60 min before 
injection. Immediately before injection, the gas was decanted 
from an g-ml sample of sonicated dextrose albumin. The g-ml 
sample (or 4-ml concentrated sample) was then given as a 
bolus over 3 s in the femoral vein and followed with a lo-ml 
normal saline flush. Each agent-gas mixture was given twice to 
test reproducibility. This same mixture was then given during 
brief (five to six respiratory cycles) inhalation of the same gas 
with which the sonicated dextrose albumin had been incubated 
before intravenous injection. This procedure was used in an 
stteinpt to temporarily saturate the blood with the gas to 
further prevent diffusion and dissolution of the incubated gas 
during intravenous injection. The concentrated samples of sulfur 
hexafluoride-exposed microbubbles were given as 4-ml injec- 
tions. Finally, each ot the gas-exposed samples was readmiis- 
tered in each dog after the initial sequence of injections. This 
procedure ruled out the possibility that the gas from a previously 
injected gas-exposed microbubble sample contributed to the 
results of the subsequent gas-exposed sample. 
The left ventricular cavity and myocardial contrast pro- 
duced with these samples were analyzed off line at end-systole 
from videotape images with the use of contrast software on the 
Freeland Systems Prism Review Station. This software digi- 
tizes up to 30 frames at one point in the cardiac cycle and will 
quantify gray scale (0 to 255 shades of gray) from a loo-square 
pixel region of interest within the mid-left ventricular cavity 
and anterior myocardium. These values were used to calculate 
peak videointensity in each region. 
Mean transit time of contrast appearance in the left ven- 
tricular cavity and myocardium was measured by using on-lint 
software (Acoustic Densitomstry; Hewlett Packard Sonos 1500 
Ultrasound System). This software calculates mean transit 
time as the sum of background-subtracted videointensities 
multiplied by the time of appearance in the left ventricular 
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Table 2. Hemodynamic Measurements After Intravenous Injection 
of Sonicated Dextrose Albumin Exposed to D&rent Gases” 
-----.- . . -._- -----__- -. - 
Frcwres (mm t<g) 
SDA RA 
SDA Nitro 
SDA Nitro t inh 
SDA He 
SDA He + inh 
SDA SF 
SDA SF + inh 
SDA SF Cone 
Mean PA 
. . . .-___- 
15.3 2 3.5 
16.7 2 3.1 
14 b 2 2.7 
16.6 IT 3.2 
15.8 T 3.2 
15.9 t 4.1 
15.0 ‘t 2.0 
14.3 1‘ 3.3 
LV SyWlic LV End-Diastolic 
118.U i 19 I 
I IO.6 t 13.6 
llt9.U L 6.1 
ilY.l I 16.Y 
116.6 z 1Y.X 
118.2 + 17.5 
I I I .lJ t 15.1 
111.6 + 10.X 
4.7 L 3.2 
6.0 z 5.7 
3.5 f 1.7 
4.5 i- 2.5 
4.0 r 3.8 
6.3 + 2.1 
4.7 Y 1.3 
6.U z 2.U 
There were no significant differences berween samples. AlI data are pre- 
sented as mean value + SD. He = h&m; inh = inhalation with the incubated 
gas; LV = left ventricular; Nitro = nitrogen; PA = pulmonary artery; RA = 
room air rxposure; SDA = sonicated dextrose albumin: SF = sulfur hexafluo- 
ride; SF Cone = 4. or &fold concentratJ bolus of s.dfur hexaHuoride. 
cavity or myocardium divided by the sum of all background- 
subtracted videointensities. 
VisuaNy discernible myocardial contrast in the anterior 
myocardium was also assessed by two experienced reviewers. 
The contrast was graded qualiiatively as 0 = no contrast, If = 
some visual contrast, 2t = moderate rontrast, and 3+ = 
marked contrast resulting in an appearance similar to that of 
cavity contrast. 
Statistical analysis. The central hypothesis was that the 
highest left ventricular and mjocardial videointensities will be 
produced by the contrast agent incubated with the least soluble 
gas with the lowest diffusion coefficient during simultaneous 
inhalation of that gas. Sulfur hexafluoride was the least soluble 
and diffusible of the gases chosen for this study (Table I). 
Analysis of variance of the peak videointensities in the left 
ventricle and myocardium of each of the different gas-expased 
contrast agents was used for comparison. A Student-Xewman- 
Keuls multiple comparison procedure was used to ccbmpare 
groups. Reproducibility of left ventricular cavity or myocardial 
contrast was determined by calcula!ing the coefficient of 
variation of the contrast produced by repeated intravenous 
injections of the same gas-exposed agent. 
Rest&s 
Hemodynamic variables during intravenous contrast injec- 
tions. Table 2 demonstrates the left ventricular systolic, end- 
diastolic and mean pulmonary artery pressures after the injec- 
tions. There were no significant changes in pulmonary artery or 
left ventricular pressures during injection of any of the samples 
exposed to different gases. 
Table 3 demonstrates mean microbubble size and concen- 
tration for sonicated 5% dextrose albumin alone and after 
exposure to nitrogen, helium and sulfur hexafluoride. Micro- 
bubble size was not different among the samples, but micro- 
bubble concentration of the helium- and nitrogen-containing 
samples was significantly less than those exposed to sulfur 
hexafluoride or room air alone. 
Table 3. Mic. ~hutrolc Size and Concentration of Sonicated Dextrose 
Albumin Exposed to Ditferrnt GIXS 
-- ---l_ --_- ----._-.I__----_Iz_ 
Swi SD;\ 
R.4 Yittu SDA llc’ WA Sk 
Buhbk w (km) 5.1 i 2.4 5.6 -t 23 5.6 + 1 Y 5.5 z I 2 
Uuhblc conxntratwn 4.1 f 0.1 .x7 c 0.4" 3.3 t u.?' a.1 2 (1.1 
(X lOhI) 
---l_l__ __ 
‘p C U.05 versus Wnicated deartne zalbumin expoxd lo room air and sulfur 
hexatluoride. All data arc pre\ented as mean w!uc ? SD. Abbreviation5 as in 
7bhle ?. 
Differences in left ventricular cavity opacification. The 
total number of intravenous injections in the study has 229, 
and the average number of injections in the 13 dogs studied 
was 18. Table 4 dis,)lays differences in left ventricular cavity 
opacification at eild-sysrole after each of the different gas- 
exposed sonicdted dextrose albumin injections. ~‘nere was a 
progressive increase in peak videointensiiy in the left venlri,zle 
as the blood solubility of ihe microbubble gas decreased 
(nitrogen, helium and sulfur hexatluoride). For each of these 
gases, the chamber videointensity produced with the sample 
was significandy increased when rhe gas was ulso inhaled briefly 
during the period of intravenous injection. The highest end- 
systolic left ventricular peak videointensity of the nonconcen- 
trated samples was produced by the gas with the lowest blood 
solubihty and highest molecular weight (the sulfur hexafluoride- 
exposed sonicated dextrose albumin microbubbles) when given 
during brief inhalation with sulfur hexailuoride (gray scale U 
139 -C 10 vs. for 54 -C 11 sonicated dextrose albumin alone and 
122 -C 8 for sonicated dextrose albumin exposed to sulfur 
hexafluoride but given during room air inhalation, p < 0.001). 
Figure 1 demonstrates the significant increase in left ventricuiar 
cavity opacification with sulfur hexafluoride-exposed micro- 
bubbles. 
Differences in myocardial contrast with different gas expo- 
sure. Table 4 also demonstrates the myocardial contrast pro- 
duced by sonicated dextrose albumin exposed to different 
gates. Although nonconcentra!cd sonicated dextrose albumin 
microbubbles exposed lo 100 St helium, 100% nitrogen and 
100% sulfur hexafltioride and then given during inhalation of 
these same gases all produced significantly higher left ventric- 
ular cavity contrast, there was no visual and minimal quantifi- 
able contrast in the anterior myccardium. 
The only gas-exposed microbubbles that ivere concentrated 
were the sulfur hexafluoride-exposed sonicated dextrose aibu- 
min microbubbles. This procedure was followed because sulfur 
hexafiuoride produced the highest left ventricular cavity vi&o- 
intensity of the different nonconcentrated gas-exposed micro- 
bubbles. The &fold concentrated sulfur htxafiucride -mctibated 
microbubbles given during inhalation of sulfur hex$uoride pro- 
duced significantly higher myocardial Lontras? (Table 4). 
Visually discernible contrast of myocz.rdial contrast me- 
dium was evident with the concentrated sulfur hexafluoride 
microbubbles. This visual myocardial contrast corresponded to 
peak videointensities (corrected for baseline) >15 U. ‘I& two 
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Table 4. Peak Videointensity at End-Systole in the Left Ventricular Cavity and Myocardium Produced bv Intravenous Sonicated Dextrose 
Albumin Exposed to Different Gases 
SDA 
Nitro + SDA He SDA SF + SDA SF 
PVI SDA RA WA Nitro Inh SDA He + Inh SDA SF Inh Cone I______ 
LV 542 11 78 2 15* loo 2 7* 82 t 13* 103 2 x* 122 t 8s 139 i lot 152 t R$ 
MY0 1.8 2 1.9 2.7 -c 1.1 3.5 +_ 2.5 4.0 + 3.2 5.2 t 2.2 8.9 t 3.7’ 11.8 + 3.7* 17.4 + 2.2$ 
*, i, $p < 0.05 versus, respectively, sonicated dextrose albumin with room air exposure, all other nonconcentrated samples, all other samples, as assessed by analysis 
of variance. All data are presented as gray scale units. LV = left ventricular cavity: MY0 = myocardium; PVI = peak videointensity; other abbreviations as in Table 2. 
experienced reviewers detected 1+ or greater visual myocar- 
dial contrast in 9 (81%) of the I1 intravenous injections of the 
&fold concentrated bolus of sulfur hexafluoride microbubbles 
when given during brief inhalation of sulfur hexafluoride. 
There was visually discernible myocardial contrast in 6 (50%) 
of the 12 4-fold concentrated samples. The two reviewers were 
in agreement on the degree of uptake (within 1 degree) in all 
cases. However, in each of the dogs, the inferior and posterior 
walls could not be visualized because of acoustic shadowing 
due :o the microbubbles i~ the left ventricular cavity. The 
mean transit time of contrast medium in the myocardium after 
administration of the concentrated sulfur hexafluoride- 
exposed sonicated devtrnse albuAn was 11.5 + 1.5 s (range 8.4 
to 13.2), whereas mean transit time in the left ventricular cavity 
of tf;r.br ~~mcentrated microbubble solutions was 12.8 2 1.5 s 
(Fig. 2). Figure 3 is an example of myocardial contrast after 
an intrave!lous injection of a concentrated bolus of sulfur 
hexafluoride-incubated microbubbles during inhalation of this 
gas. 
Reproducibility of left ventricular cavity and myocardial 
contrast. Left ventricular cavity videointensity with the same 
amount of contrast medium and same gas exposure was tested 
twice to assess reproducibility of the findings. The coefficient of 
variation for peak left ventricular cavity videointensity for the 
sulfur hexafluoride-exposed microbubbles in all dogs was 
7.1%. The coefficient of variation for myocardial contrast of 
the concentrated samples of the sulfur hexafluoride-enhanced 
microbubbles in all dogs was 13.0%. 
Discussion 
I hese results demonstrate that intravenous sonicated dex- 
trose albumin can reliably produce myocardial echocardio- 
graphic contrast when the microbubbles are filled with a high 
molecular weight (and thus less diffusible), less soluble gas 
before injection. The sonicated dextrose albumin incubated 
with sulfur hexafluoride, the gas of lowest blood solubility and 
dilfusivity, produced the greatest left ventricular and myocar- 
dial contrast. Sulfur hexafluoride is a physiologically inert 
agent used is an inhaled gas beca,;e of its low diffusivity and 
solubility (11) and in intravitreal injections for retinal tampon- 
ade because of its low difisivity (12). In each of these clinical 
applications, there has been no apparent toxicity. Similarly, 
Figure 1. Epicardial short-axis images at en& 
q&Ae of the left ventricular cavity at basetile 
(BASE, center image) and during injection of the 
same amount of sonicated extrose albumin ex- 
posed to room air (RA), nitrogen (N2), sulfcr 
hexafluoride (SF) and helium (He). The soni- 
cated dextrose albumin exposed to sulfur 
hexafiuoride produced the greatest left ventricu- 
lar opacification. 
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Figure 2. Time-intensity curves in the left vcr.triculal cavity (LV) and 
myocardium (Myo) after an intravenous injection of the concentrated 
sulfur hexafluoride-exposed sonicated dextrose albumin micro- 
bubbles. The left ventricular cavity videointensity was blunted at peak 
intensity becduse of acoustic shadowing (arrow). PVI = peak video- 
intensity. 
sulfur hexafluoride-exposed dextrose albumin microbubbles 
had nc adverse hemodynamic effects in this study. 
Both microbubble gas diffusivity and blood soiubility ap- 
peared to be important determinants of the degree of left 
ventricular ultrasound opacification. The purpose of this 
Fioject was to alter these two physical characteristics of the 
microbubble gas to prolong microbubble survival. Altering 
each of these known properties of gases produced micro- 
bubbles that could significantly enhance the clinical application 
of sonicated dextrose albumin. 
Effect of microbubble gas dithivity. It has been shown 
(13) that the rate of microbubble radius decay in blood is 
directly related to the diffusion constant for a given gas. The 
rate of diffusion of a gas is inversely proportional to the square 
root of the moleculnr weight (8). Sulfur hexafluoride has a 
molecular weight of 146 g/mol, in contrast to 4 g/m01 for 
helium and 28 @noi for nitrogen. Therefore, sulfur hexafluo- 
ride will diffuse more slowly down the concentration gradient 
from the microbubble into blood. This will prevent the micrc- 
bubble from shrinking and preserve its reflective proper- 
ties and explains why the best left ventricular ultrasound con- 
trast after intravenous injection was obtained with the sulfur 
hexalluoride-exposed microbubbles. 
In our study, inhalation of sulfur hexafluoride during the 
intravenous injection of sulfur hexailuoride-containing dex- 
trose albumin microbubbles should have decreased th  concen- 
tration gradient. We hypothesized that the inhalation would 
delay diffusion of sulfur hexafluoride gas from within the 
microbubble. Because the inhalation significantly improved 
left ventricular cavity and myocardial opacification, we assume 
that the delayed diffusion is one mechanism for this im- 
provement. The opposite clinical results have been seen when 
the concentration gradient of smaller molecular weight gases 
Figure 3. Epicardial short-axis images before (left) and after (tight) 
femoral venous injection of concentrated sonicated extrose albumin 
exposed to sulfur hexafluoiide before injection and administered 
during brief inhalation of a partial mixture of room air and sulfur 
hexafluoride. Myocardiai uptake is visually evident. BASE = baseline; 
SF = concentrated boius of sulfur hexafluoride microbubbles given 
intravenously during brief inhalation with sulfur hexafluoride. 
like nitrogen is increased. Wible et al. (14) demonstrated loss 
of left ventricular cavity opacification when predominantly 
nitrogen-containing albumin microbubbles were given intrave- 
nously during inhalation of 100% oxygen and 0% nitrogen. 
When we administered 100% nitrogen with the nitrogen- 
containing dextrose albumin microbubbles, we saw improved 
left ventricular videointensity by decreasing this concentration 
gradient (Table 4). 
Effect of microbubble gas solubility. Exposing intrave- 
nously injected albumin microbubbles to gases like nitrous 
oxide that have increased blood soiubility (15) results in a 
shorter duration of contrast effect (14). Sulfur hexafluoride 
and helium are gases with significantly lower blood solubility 
than that of nitrous oxide (16). In our study, both of these gases 
produced significantly higher left ventricular chamber opacifi- 
cation after intravenous injection than did the same amount of 
sonicated dextrose albumin exposed to room air (Table 4). 
Because: helium-incubated microbubbles produced greater left 
vemricular cavity opacification than did room air-containing 
microbubbles, this study demonstrates the relative importance 
of Mood solubility as well as diffusivity in determining micro- 
bubble survival. Helium has a mo!ecuiar weight of only 4 gimoi 
and is therefore rapidly diffusible. However, it is less blood 
soluble than either nitrogen or room air (8). Because the 
micrcbubbles incubated in helium produced greater left ven- 
tricular opacification than did room air-containing micro- 
bubbles, blood solubility must be as important as diffisivity in 
determining microbubble survival in blood. 
The low blood soiubility of sulfur hexafluoride may also 
explain why inhaling a small amount of this gas during 
intravenous injection of the sulfur hexafluoride-containing 
microbubbles produced the greatest left ventricular chamber 
and myocardiai opacification. If this inhalation saturated, or 
even supersaturated, blood with sulfur hexaflunride during 
intravenous injection, it wou!d have prevented the gas from 
dissolving and preserved microbubble size (13). 
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Effect of bolus delivery of contrast agent. Villanueva et al. 
(1) have demonstrated that concentrated boluses of sonicated 
albumin produce visually discernible myocardial contrast in 
50% of right atria1 injections under baseline conditions (1). 
The concentration of albumin microbubbles required to 
achieve this were 4 to 5 X 108/ml. By concentrating the sulfur 
hexafluoride-exposed microbubbles g-fold, we were able to 
produce visually discernible myocardial uptake in >80% of 
femoral venous injections under baseline conditions. Visual 
detection in the myocardium was not evident with smaller 
concentrations of the sulfur hexafluoride-exposed micro- 
bubbles, although videointensity was quantitatively increased. 
Visually discernible myocardial contrast did not occur until 
vi&ointensity (corrected for baseline) exceeded 15 gray scale 
units (Table 4). The improved videointensity with highly 
concentrated boluses of these microbubbles is consistent with 
previous observations (16) that the gas-filtering effect of the 
lung becomes less efficient when exposed i:~ high concentra- 
tions of the gas. 
Limitations of the study. External exposure of sonicated 
dextrose albumin microbubbles to sulfur hexafluoride gas 
resulted in myocardial opacification after intravenous injection 
that was not produced with the same microbubbles exposed to 
room air, IOU% nitrogen or 100% helium. Although this 
finding supports the hypothesis that this gas with lower diffu- 
sivity and blood solubility diffused across the microbubble 
membrane and prevented the microbubble from shrinking 
after intravenous injection, the proof we obtained for this 
hypothesis was inferential rather than direct. However, albu- 
min microbubbles have been shown to be extremely sensitive 
to the surrounding gas (14), suggesting that the protein shell 
allows rapid diffusion of gases across irs membrane. Because 
we assumed that sulfur hexafluoride diffused more slowly than 
the other gases, sonicated dextrose albumin was incubated with 
100% sulfur hexafluoride for 60 min. However, we did not 
directly measure the partial pressure of sulfur hexafluoride 
within the microbubbles after incubation. 
In addition to this theoretical limitation, there are other 
limitations in using this technique to noninvasively measure 
myocardial blood flow. First, despite excellent quantifiable 
opacification of the anterior myocardium in >80% of the 
injections performed at rest, posterior left ventricular attenu- 
ation prevented analysis of the posterior myocardium. This 
attenuation has also been seen with high concentrations of 
Albunex and has limited the ability of this technique to 
quantify blood flow in the posterior wall by using venous 
injections of contrast medium (1). One factor producing 
attenuation with albumin microbubbles appears to be the large 
number of small (~3 vrn) microbubbles (13). These micro- 
bubbles produce very little reflection but still cause attenua- 
tion. Therefore, because of the rapid diffusion of gases out of 
the mic,cbubble after intravenous injection, the major+ of 
microbubbles will be in this size range by the time they reach 
the left lfentricle after a peripheral intravenous injection. Even 
though ‘we altered microbubble gas to make it less diffusible 
and less blood soluble than oxygen or nitrogen, there was still 
considerable attenuation in the left ventricular cavity (Fig. 3). 
It is imperative to maintain microbubble size in the 5 to 6 pm 
range, because this size range producss a better reflection/ 
attenuation ratio when transmitted frequencies are 2.5 to 
3.5 MHz (13). 
Second, for the sulfur hexafluoride-exposed sonicated dex- 
trose albumin to produce myocardial contrast, the injection 
had to be given during simultaneous inhalation of sulfur 
hexafuoride. Although it may not be realistic to expect inha- 
!ation of sulfur hexafluoride gas combined with injection of 
sulfur hexafluoride-containing microbubbles to be a clinical 
approach to noninvasive perfusion imaging, this finding sup- 
ports the concept that altering microbubble gas composition to 
decrease diffusivi& and blood solubility will improve the contrast 
efecr in the le$ ventrkular cavity and myocardium. 
Conclusions. In this study, sonicated dextrose albumin 
microbubble gas composition was altered by incubating the 
micrtibubbles with sulfur hexafluoride, a gas with lower levels 
of ditisivity and blood solubility than those of nitrogen or 
oxygen. Intravenous injection of a concentrated bolus of these 
microbubbles produced significantly higher left ventricular 
opacification and visually evident myocardial opacification. Be- 
cause the injection also produced consistent acoustic shadow- 
ing of the posterior myocardium, further modifications are 
needed before this contrast agent is applied to the noninvasive 
study of myocardial blood flow. Other methods of improving 
the amount of these gases incorporated into the microbubble 
need to be explored. Clinically accepted techniques for doing 
this already exist (17). In addition, the intravascular rheology 
of these microbubbles must be examined to confirm that they 
act as red blood cell tracers and therefore can be utilized as 
indicators of myocardial blood flow. The mean transit time of 
contrast medium in the myocardium that we observed after the 
intravenous concentrated sulfur hexafluoride-incubated dex- 
trose albumin microbubble injections indicates that they do 
behave G L~travascular tracers. Therefore, altering micro- 
bubble gas composition represents an exciting new technique 
that may allow contrast echocardiography to be utilized in 
noninvasive studies of myocardial blood flow, 
We thank Patricia Dunham for assistance in the preparation of the manuscript. 
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